Benzinga's Top Downgrades

Loading...
Loading...
Analysts at Credit Suisse downgraded BIND Therapeutics
BIND
from Outperform to Neutral. The price target for BIND Therapeutics has been lowered from $20 to $10. BIND Therapeutics' shares closed at $6.72 yesterday. Analysts at BB&T Capital downgraded CIRCOR International
CIR
from Buy to Hold and removed the price target of $85. CIRCOR International's shares closed at $64.79 yesterday. Analysts at BMO Capital downgraded Thor Industries
THO
from Outperform to Market Perform. The price target for Thor Industries has been lowered from $62 to $54. Thor Industries' shares closed at $57.89 yesterday. Analysts at Leerink Swann downgraded Kindred Biosciences
KIN
from Outperform to Market Perform. The price target for Kindred Biosciences has been lowered from $11.25 to $6. Kindred Biosciences' shares closed at $9.24 yesterday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...